Clinical Trial Search Results

Clinical Trial Search Results

Showing 1-8 of 8

Sorted By:

  • Genentech NSABP B-59

    A Randomized, Double-Blind, Phase III Clinical Trial of Neoadjuvant Chemotherapy with Atezolizumab or Placebo in Patients with Triple-Negative Breast Cancer Followed by Adjuvant Continuation of Atezolizumab or Placebo

  • MK-3475-756/KEYNOTE-756 USOR 17188

    Study of Pembrolizumab Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage ER+/HER2- Breast Cancer

  • POLARIS: USOR 16128

    Palbociclib in Hormone Receptor Positive Advanced Breast Cancer, Non-Interventional

  • USOR 17009

    The primary objective of the study is to compare the efficacy of tesetaxel plus a reduced dose of capecitabine versus the approved dose of capecitabine alone based on progression-free survival (PFS) as assessed by an Independent Radiologic Review Committee (IRC).

  • USOR 17079

    Patients with stage I to III breast cancer are eligible for entry into the FLEX Registry.

  • USOR 17082

    Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer.

  • USOR 18167

    A Study to Evaluate Patient Preference and Satisfaction of Subcutaneous Administration of the Fixed-Dose Combination of Pertuzumab and Trastuzumab in Participants With HER2-Positive Early Breast Cancer

  • USOR 18232

    A Study to Evaluate Safety/Tolerability of Immunotherapy Combinations in Participants With Triple-Negative Breast Cancer and Gynecologic (ovarian) Malignancies

Find a Doctor

Find an Adventist HealthCare affiliated doctor by calling our FREE physician referral service at 800-642-0101 or by searching our online physician directory.

View Doctors

Set Your Location

Setting your location helps us to show you nearby providers and locations based on your healthcare needs.